Forbes January 8, 2026
Christopher C. Thompson, MD, MSc

Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week and could change obesity care. Here’s how the Wegovy pill works, who qualifies, how to take it, side effects, cost, and what this means for treatment now.

Novo Nordisk has launched the Wegovy weight loss pill in the United States, removing one of the biggest barriers that has limited GLP-1 weight loss treatment – injections.

I see this hesitation regularly in clinic. Patients who qualify for GLP-1 therapy, understand the benefits, and want to lose weight still decline treatment because they do not want weekly injections. The pill does not change the biology. It changes the decision point.

The Wegovy pill contains the same active ingredient as injectable Wegovy,...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat

Share Article